Skip to main content
Equibles

Jonathan Lim

Chairman

Erasca, Inc. (ERAS)

CEO

Erasca, Inc. (ERAS)

Board Member

Maze Therapeutics, Inc. (MAZE)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jonathan Lim

Jonathan Lim is recorded as Chairman and CEO at Erasca, Inc. (ERAS) and Board Member at Maze Therapeutics, Inc. (MAZE). The proxy statement of Erasca, Inc. reports total compensation of $4,298,838 for Jonathan Lim in fiscal 2025, including a base salary of $670,400. Disclosed compensation is on record for 6 fiscal years. Jonathan Lim has spoken on 1 investor event across 1 company, most recently for Erasca, Inc. on September 15, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Erasca, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Maze Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Erasca, Inc. (ERAS) $670,400 $4,298,838
2024 Erasca, Inc. (ERAS) $644,600 $3,894,032
2023 Erasca, Inc. (ERAS) $622,800 $5,407,446
2022 Erasca, Inc. (ERAS) $593,100 $7,523,335
2021 Erasca, Inc. (ERAS) $497,846 $850,234
2020 Erasca, Inc. (ERAS) $300,000 $1,964,696

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.